$HRL

Stephens Increases Hormel Foods (HRL) Price Objective but Stays Neutral

On May 29, Stephens raised its price objective for Hormel Foods (HRL) to $25 from $22 but kept an Equal Weight rating, citing a Q2 adjusted EPS beat without guidance increases or clearer second-half execution. On the same day, BofA lifted its price target to $25 from $23 and maintained Neutral, saying the stock’s reaction reflected relief and that execution confidence is improving.

Original reporting
Published May 31, 2026, 2:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 31, 2026, 3:10 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stephens Increases Hormel Foods (HRL) Price Objective but Stays Neutral — source image
Decision brief

The 30-second read

$HRLNeutralLow
01

Why it matters

The main actionable takeaway is that sell-side optimism improved slightly (higher targets) while conviction remains constrained by the absence of guidance increases and a need for clearer second-half execution.

02

Market read

Analyst target hikes provide mild support, but unchanged ratings and no guidance raise imply the stock’s next leg likely depends on execution/guidance clarity.

03

What to watch

The article stresses “conservatism” in management assumptions; traders may need to watch whether subsequent quarters validate those assumptions rather than rely on target revisions.

Relevance 7/10Novelty 4/10Timing: post-earnings analyst note (published pre-market/early session)

Background

The piece references Hormel’s Q2 adjusted EPS beat and discusses how two sell-side firms responded with higher price targets but unchanged ratings.

Company-level read

Ticker impact

$HRLNeutralMedium confidence
Context

Stephens raised Hormel Foods’ price target to $25 from $22 while keeping Equal Weight, citing lack of guidance increase despite a Q2 EPS beat.

Expected impact

Likely limited near-term upside; could support the stock on dips but not drive a breakout without new guidance/execution evidence.

Evidence & confidence

Both Stephens and BofA kept Neutral/Equal Weight and highlighted that guidance did not rise; the article is analyst-framing rather than a new company datapoint.

Market effects

Reinforces cautious sentiment toward branded food execution versus expectations, with dividend yield support remaining a key narrative.

No specific regional spillover indicated.

No direct global macro or international supply-chain shock mentioned.

Counterpoint

If the market was already pricing the Q2 beat, target increases may have diminishing marginal impact without forward guidance upgrades.

Key entities

  • Hormel Foods Corporation

    Branded food company; subject of the analyst target/rating changes discussed.

  • Stephens

    Raised HRL price target to $25 from $22; kept Equal Weight.

  • BofA

    Raised HRL price target to $25 from $23; maintained Neutral.

Related articles

$HRLMed

Hormel Foods’ president John Ghingo takes CEO seat from Jeff Ettinger

Hormel Foods named President John Ghingo as CEO, replacing Jeff Ettinger, effective 26 October. Ettinger will remain on the board. The change follows Ettinger’s interim appointment last year and prior leadership shifts. In June, Hormel guided 2026 sales revenue to $12.2bn-$12.5bn and oversaw asset sales including whole-bird turkey to Life-Science Innovations and Brazil business to Zanchetta Alimentos.

$HRLMed

Spam maker exits entire market

Hormel Foods (HRL) agreed to sell its Brazilian Ceratti operations to Zanchetta Alimentos LTDA, with terms undisclosed. Hormel said the divestiture simplifies its portfolio and targets markets with stronger growth. The deal is expected to close in coming weeks, subject to approvals, and is expected to have minimal impact on adjusted fiscal 2026 results.

$HRLMedAI 8/10

Was Hormel’s Q2 Earnings Report the Turnaround Investors Needed?

Hormel reported Q2 progress on its Transform & Modernize (T&M) program, citing improved turkey manufacturing performance, lower Retail selling, general and administrative expenses, and a favorable product mix. The Jennie-O whole-bird turkey sale closed this quarter, causing a $61 million GAAP loss excluded from adjusted results. Hormel kept FY net sales guidance at $12.2–$12.5B and adjusted EPS at $1.43–$1.51, while GAAP EPS guidance fell to $1.28–$1.37.

$ARMMedAI 9/10

Stocks Rebound Amid News of a US-Iran Deal

US Q1 GDP was revised to +1.6% (q/q annualized) from +2.0% expected; Q1 personal consumption was cut to +1.4%, while core PCE rose to a 3-year high of +4.4%. Apr new home sales fell 6.2% m/m to 622k. Stocks rebounded after Axios reported a preliminary US-Iran deal to extend the ceasefire 60 days and begin nuclear talks. Fed hawkishness weighed; markets priced a 3% chance of a 25 bp June cut.